GlassScriptPhysician profile
Xylina D Bean
NPI 1871515254
$378.26
in general payments reported to CMS, 2019-2025
9 companies · $38.97 in 2025
The $38.97 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.67 · 2021: $70.64 · 2022: $53.74 · 2023: $81.47 · 2024: $79.77 · 2025: $38.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $142.25 | 2021-2024 | Bexsero, Pediarix, Rotarix |
| Pfizer INC. | $53.82 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $43.86 | 2023-2024 | Gardasil 9, Vaxneuvance, Proquad |
| Sanofi Pasteur INC. | $32.33 | 2019-2021 | |
| Phadia US INC. | $31.57 | 2019-2023 | Immunocap |
| Hologic Sales and Service, LLC | $22.92 | 2025 | Aptima |
| Sanofi-Aventis U.S. LLC | $19.75 | 2024 | |
| Seqirus USA INC | $16.05 | 2025 | Flucelvax |
| Alexion Pharmaceuticals, INC. | $15.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xylina Bean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.